Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-27 @ 6:49 AM
Study NCT ID:
NCT02659020
Status:
COMPLETED
Last Update Posted:
2022-05-09
First Post:
2016-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
15839
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None